Catabasis Pharmaceuticals to raise about $110m in private placement
Catabasis Pharmaceuticals, a biopharmaceutical company, has inked about $110 million in a private placement.
29 January 2021•5 mins read
Catabasis Pharmaceuticals, a biopharmaceutical company, has inked about $110 million in a private placement.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
23 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
23 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
23 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
23 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
23 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
24 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 November 2026 · 3 mins read
